+44 (0) 20 7079 4399
Call HCA from 8am-8pm Mon-Fri and 9am-5pm Sat
HCA Healthcare UK
Dr Michael Feher
MB BS, MD, FRCP
Lipids, Diabetes, New diabetes therapies, Insulin Pump therapy, Hypertension, Obesity, Cardiovascular Risk Factors, Thyroid conditions, Adult Refsums disease
Dr Michael Feher is Consultant Physician at Wellington Hospital, and Consultant Physician and Clinical Lead for lipid, diabetes, and hypertension service at Chelsea & Westminster Hospital, London. He is also Visiting Associate Clinical Professor of the Department of Epidemiology & Population Health at the Albert Einstein School of Medicine in NewYork, USA, and Honorary Reader at CSRI Warwick Medical School in Warwick, UK.Dr Feher has developed and currently leads several unique specialist services including lipid clinics in adults (joint with chemical pathology) and family lipids (joint with paediatrics), new diabetes therapies, liaison-psychiatry-diabetes, HIV-diabetes, insulin pump and diabetic hypertension. He is currently diabetes assessor to London Metropolitan/Home County Police and London Ambulance Services and diabetes adviser to British National Formulary. National /International committees include: NICE Committees for statins and type 2 diabetes, European Medicine Agency diabetes representative and DVLA panel for diabetes.Over the past twenty five years Dr Feher has had extensive clinical experience in the fields of lipids, diabetes, and hypertension. He has made considerable advances in combining clinical pharmacology, pharmaco-epidemiology and laboratory-based research with diabetes clinical care and teaching. He was cofounder of the Diabetes Therapies Evaluation Network (DTEN), which is a research group, established to specifically evaluate phase 4 and early introduction into clinical practice of new therapies specific to diabetes. He has published extensively in the fields of lipids and lipid disorders, diabetes, hypertension, cardiovascular risk factors and clinical pharmacology, with over 150 publications and 8 books in diabetes and cardiovascular medicine.
Call the contact centre
+44 (0) 20 7079 4399
8am-8pm Mon-Fri, 9am-5pm Sat
Let us call you backCan we call you back at a more convenient time
Email contact centreSend us an email and we will get back to you.
© copyright 2008 - 2017 HCA Healthcare UK.
Registered Name: HCA International Limited; The part of the UK in which it is registered: England and Wales;
Registered Number: 03020522; Registered Office Address: 242 Marylebone Road London NW1 6JL.
£500m has been invested by HCA International in the latest medical technologies and facilities over the last 10 years.
Your hospital will be one of our world-class private hospitals: HCA’s world-class hospitals are accredited by The CHKS Accreditation Unit, a leading provider of healthcare intelligence and quality improvement services. The accreditation is a measure of the overall quality of a hospital and hospitals with CHKS accreditation have been shown to provide a better quality of service.
Your safety will be protected because we have more critical care beds than any other private hospital group: HCA hospitals achieved 100% compliance with all Care Quality Commission inspected outcomes of care in 2011.
Your treatment will be undertaken using the most advanced diagnostic and treatment facilities: Oliver Wyman, Corporate Accounts: Driving quality and value, January 2012.